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ExPHT was associated with reduced cardiac event-free survival (27±7%
vs. 53±9%, p=0.02). In multivariate Cox proportional hazard model, the inde-
pendent predictors of events were resting E/Ea ratio (p=0.01), aortic peak
velocity (p<0.0001), indexed left atrium area (p=0.005), LV global longitu-
dinal strain (p=0.04) and ExPHT (hazard ratio=1.9, p=0.04). When adding Ex-
induced changes in aortic mean gradient to the multivariate model, ExPHT
remained an independent predictor outcome (p=0.033).
Conclusion: In asymptomatic patients with severe AS, the main determinants
of ExPHT are the severity of AS and the Ex-induced changes in LV filling pres-
sure. ExPHT is associated with 2-fold increased risk of cardiac events.
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The mitral stenosis (MS) is the most common valvular disease in the
Maghreb; young women of procreation age are most concerned.
Percutaneous mitral commissurotomy (PMC) has changed the prognosis of
symptomatic MS of pregnant woman.
We report our experience on eighty-three patients requiring PMC during
the third trimester of pregnancy, between March 1998 and May 2010.
Their mean age was 29±4, 9 years; the presumed age of pregnancy was
27.5±2.9 weeks of gestation. Fifteen were in New York Heart Association
class II; fifty in class III and eighteen in class IV. Twelve patients with atrial
fibrillation. Wilkins score calculated in all patients with an average 7±2.
No fetal deaths were noted after the procedure. 1 case of stroke, transient.
No abortions occurred following the procedure.
We report a maternal death fifteen days after delivery. All patients have
improved after the surgery at least one class of NYHA.
Mitral surface area and hemodynamic parameters improved significantly
after PMC; mean left atrial pressure fell from 30±6.3 to 12.2±7 mmHg, mean
transmitral gradient from 21±7.2 to 6.1±3.2 mmHg and mitral valve area from
0.8±0.15 to 2.15±0.2 cm2.
During pregnancy the PMC is the treatment of choice of MS must be per-
formed by an experienced team because the angle of the trans septal puncture
is subject to changes in pregnant women.
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Objectives: This study analyzed the association between pre-operative rest
echocardiography and the 6-month post-operative left ventricular ejection
fraction (LVEF) in organic mitral regurgitation (MR).
Background: LV end-systolic diameter is the marker of LV function in
patients with organic MR associated to survival and post-operative EF, but
still some patients have nowadays a depressed post-operative LV EF despite
correct diameters.
Methods: 88 patients (62.6±1.4 yo) were prospectively recruited. They all
got a complete echocardiography including the assessment of LV-deforma-
tions before the MR repair and all had an echocardiography at 6-month after-
surgery. Exclusion criteria were: coronary artery disease, other organic val-
vular disease, uncontrolled arrhythmia, hemodynamic instability.
Results: The principal parameters not correlated to post-operative LVEF
(0.5±0.08) are displayed in table I. The univariate analysis concluded that: LV
end-systolic diameter (36±0.7 mm, R=–0.34, p=0.009); Left atrial area
(26.4±1.0 cm²; R=–0.37, p=0.011); LV end-diastolic volume (149.9±5.2 ml;
R=–0.31, p=0.019); LV end-systolic volume (52.3±2.5 ml; R=–0.35,
p=0.003); Mitral annulus diameter (37±0.7 mm; R=–0.25; p=0.01). Using a
multivariate linear regression, the GLS/LV end-systolic volume (–4.6±0.3;
p=0.01) and the left atrial diameter (44.7±0.8 mm; p=0.01) were the best pre-
dictor of post-operative LVEF (R²=0.22).
Conclusions: In organic MR, LV end-systolic diameter is a key parameter
to propose surgery. We demonstrated that global longitudinal strain (GLS, %)
normalized for the end-systolic volume is, with the LA size, an important
determinant of post-operative EF.
Table – Main results
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Background: There is uncertainty and debate regarding whether ischemic
mitral regurgitation (MR) is a secondary epiphenomenon resulting from left
ventricular (LV) dysfunction or confers an independent effect on exercise
capacity and outcomes.
Objective: We tested whether ischemic MR negatively impacts exercise
capacity, cardiovascular morbidity and mortality in patients with coronary
artery disease (CAD) and inferior wall motion abnormality patients, indepen-
dent of LV dysfunction.
Methods: Clinical follow-up over 5 years was obtained in 77 patients (age
64±10 years, LVEF 54±11%) with at least mild ischemic MR from CAD and
evidence of inferior wall motion abnormality, who had exercise stress testing
with perfusion imaging within 24 hours of echocardiography. Patients with
active heart failure, ischemia, intrinsic valve disease, pulmonary and vascular
disease were excluded. Exercise capacity (METs, peak double product) was
tested for relation to MR (vena contracta (VC) and jet area), LV size and func-
tion, and pulmonary pressures. Cox proportional hazards analysis assessed
whether MR predicted cardiovascular events, including hospitalization for
heart failure, acute coronary syndrome, and myocardial infarction, and cardio-
vascular (CV) and total mortality.
Results: By multivariate analysis, independent predictors of functional
capacity (METs and peak double product) were MR vena contracta (VC;
r²=0.62, p<0.0001) and LV end-diastolic volume (EDV; r²=0.78, p=0.03). MR
jet area contributed similarly (r²=0.61, p<0.0001). MR VC >2 mm (moderate
ischemic MR) and age were independent predictors of CV events and death
(HR 6.72 for MR, p=0.04).
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mean±SE
Left atrial volume (ml) 44.7±0.8
LV end-diastolic diameter (mm) 55.9±0.9
LVEF (%) 66.2±0.8
LVOT VTI (cm) 17.3±0.5
Mitral inflow E-wave (cm/s) 91.8±5.9
S’ mitral (lateral) (cm/s) 10.4±0.4
Tricuspid maximal velocity (m/s) 2.8±0.1
